SCHEMBL14479314

SCHEMBL14479314

O=NCc1ccc(N=Nc2ccc(N=O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ CHRNA7 P36544 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12026106 0.80 MIF (0.33) ALDH1A1TSHRCYP3A4NOS3NOS1
SCHEMBL24385153 0.80 ALDH1A1 (0.50) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL18533548 0.72 TSHR (0.54) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL234461 0.71 ALDH1A1 (0.58) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL21841396 0.70 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL13711472 0.70 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL27473140 0.70 ALDH1A1 (0.42) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL14294476 0.70 HDAC3 (0.41) ALDH1A1HSD17B10TSHRTP53MAPK1
SCHEMBL11296929 0.69 HRH3 (0.50) MAPTNOS3NOS1NOS2
SCHEMBL12134592 0.69 CA1 (0.43) ALDH1A1HSD17B10TSHRTP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130004427-A1 TARGETED DENDRIMER-DRUG CONJUGATES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130004427-A1 TARGETED DENDRIMER-DRUG CONJUGATES FOLH1, DNPEP, PIGO ALDH1A1 159/4885HSD17B10 565/4885TSHR 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback